Kathmandu: Three Indian pharmaceutical companies have started supplying Nepal with life-saving anti-viral Remdesivir to be used for the treatment of COVID-19 patients."We have confirmed three companies for supply of Remdesivir.
Mylan, Cipla, and Hetero Drugs will be supplying the drugs as per our demands. We will be permitting the use of anti-viral supplied on by these companies only," Narayan Prasad Dhakal, the Director-General of Department of Drug Administration confirmed."Among them, Mylan has started supplying the anti-viral to Nepal.